<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="170477">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00877279</url>
  </required_header>
  <id_info>
    <org_study_id>MUS 90028-0717/1</org_study_id>
    <nct_id>NCT00877279</nct_id>
  </id_info>
  <brief_title>Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft</brief_title>
  <official_title>A Randomized,Blinded,Controlled,Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero® Soft, After Superficial to Mid Dermal Implantation for Correction of Mild Facial Wrinkles Over 4 Weeks.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merz Pharmaceuticals, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Merz Pharmaceuticals, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to determine the safety and effectiveness of Belotero® Soft compared to active
      comparator in the correction of mild facial wrinkles, such as nasolabial folds.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to see if Belotero® Soft is safe and effective for correction of
      mild facial wrinkles, such as nasolabial folds. The second objective of the study is to see
      if Belotero® Soft works better than the active comparator. Subjects will receive Belotero®
      Soft injection to one side of the face and the active comparator to the other side of the
      face.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The severity of the facial wrinkle</measure>
    <time_frame>2 weeks and 4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigator and subject assessments</measure>
    <time_frame>2 weeks and 4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">64</enrollment>
  <condition>Facial Wrinkles</condition>
  <arm_group>
    <arm_group_label>Belotero® Soft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Comparator will be given into the opposite side of the face that Belotero® Soft was administered for facial wrinkles, such as nasolabial folds.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CosmoDerm1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CosmoDerm1</intervention_name>
    <description>CosmoDerm1 is a single use syringe, injected into the mid dermal layer.</description>
    <arm_group_label>CosmoDerm1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Belotero Soft</intervention_name>
    <description>Dermal Filler</description>
    <arm_group_label>Belotero® Soft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects must have bilateral facial wrinkles, such as nasolabial folds

        Exclusion Criteria:

          -  Other nasolabial fold correction within 6 months prior to study entry.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rhoda Narins, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dermatology Surgery and Laser Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Skin Care &amp; Laser Physicians of Beverly Hills</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90069</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maas Clinic</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Savin Dermatology Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Coleman, III, MD</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dermatology Surgery and Laser Center</name>
      <address>
        <city>White Plains</city>
        <state>New York</state>
        <zip>10604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 23, 2013</lastchanged_date>
  <firstreceived_date>April 3, 2009</firstreceived_date>
  <firstreceived_results_disposition_date>October 12, 2011</firstreceived_results_disposition_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Facial wrinkles</keyword>
  <keyword>Nasolabial folds</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Facies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted -->
</clinical_study>
